Featured Research

from universities, journals, and other organizations

Meningitis Clotting Pathway Cracked By UK And US Scientists

Date:
August 9, 2001
Source:
Imperial College Of Science, Technology And Medicine
Summary:
Researchers in the UK and US report in the New England Journal of Medicine this week (9 August) the results of a study in children which may explain why patients with meningococcal septicaemia develop widespread clotting within blood vessels leading to death or loss of limb and digits.

Researchers in the UK and US report in the New England Journal of Medicine this week (9 August) the results of a study in children which may explain why patients with meningococcal septicaemia develop widespread clotting within blood vessels leading to death or loss of limb and digits.

The team from Imperial College and St Mary’s Hospital, London, in collaboration with research groups at the University of Bristol, UK, and Oklahoma, USA, say that their work offers new directions for treatment of the blood poisoning form of meningitis.

In healthy individuals, a number of proteins are present in the blood which act to prevent clots forming in veins and arteries. One of these is a recently identified protein called Protein C, which when activated is a powerful inhibitor of clot formation.

The NEJM study of 21 children establishes for the first time that patients suffering from meningococcal septicaemia have lost two key proteins (thrombomodulin and endothelial Protein C receptor) required to activate Protein C on the lining of blood vessels.

This serious defect leads to an inability to control clotting within arteries and veins and opens the way to widespread clot formation, a hallmark of meningococcal septicaemia, often visible as rashes on the skin.

To date the development of effective treatments to prevent or reverse this clot formation has been hampered by a lack of understanding of the mechanisms involved.

Leader of the study Professor Michael Levin of Imperial College said:

“Our study has identified a key mechanism involved in the devastating complications of meningococcal disease, and offers new insights into how the disease might best be treated.

“A defect in the activation of Protein C could, theoretically, be treated by administration of Protein C in its active form, thus by-passing the requirements for activation on the surfaces of blood vessels.”

Clinical trials are currently underway to assess the safety and feasibility of this treatment.

Denise Vaughan, Chief Executive of funders Meningitis Research Foundation said:

“We are delighted with the outcome of this research which has the potential to prevent death and disability from meningitis and septicaemia.”

The authors of the paper are Dr Saul Faust, Professor Michael Levin, Odile Harrison, Dr Robert Goldin and Dr Sheila Kondaveeti (Imperial College and St Mary’s Hospital, UK); Dr Charles Esmon and Marion Lockhart (Oklahoma Medical Research Foundation, USA); Dr Zoltan Lasik (University of Oklahoma Health Sciences Center, USA); and Dr Robert Heyderman (University of Bristol, UK).

The programme of research has been supported by a grant from the Meningitis Research Foundation grant in excess of UKP700,000, with additional support via a training fellowship from the Medical Research Council.


Story Source:

The above story is based on materials provided by Imperial College Of Science, Technology And Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Imperial College Of Science, Technology And Medicine. "Meningitis Clotting Pathway Cracked By UK And US Scientists." ScienceDaily. ScienceDaily, 9 August 2001. <www.sciencedaily.com/releases/2001/08/010809071546.htm>.
Imperial College Of Science, Technology And Medicine. (2001, August 9). Meningitis Clotting Pathway Cracked By UK And US Scientists. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2001/08/010809071546.htm
Imperial College Of Science, Technology And Medicine. "Meningitis Clotting Pathway Cracked By UK And US Scientists." ScienceDaily. www.sciencedaily.com/releases/2001/08/010809071546.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins